Infliximab-induced acne and acute localized exanthematous pustulosis: Case report

Dermatol Ther. 2017 Nov;30(6). doi: 10.1111/dth.12554. Epub 2017 Oct 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acne Vulgaris / chemically induced*
  • Acne Vulgaris / diagnosis
  • Acne Vulgaris / drug therapy
  • Acute Generalized Exanthematous Pustulosis / diagnosis
  • Acute Generalized Exanthematous Pustulosis / drug therapy
  • Acute Generalized Exanthematous Pustulosis / etiology*
  • Adult
  • Azathioprine / administration & dosage
  • Azithromycin / administration & dosage
  • Clobetasol / administration & dosage
  • Crohn Disease / diagnosis
  • Crohn Disease / drug therapy*
  • Crohn Disease / immunology
  • Drug Substitution
  • Female
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / adverse effects*
  • Glucocorticoids / administration & dosage
  • Humans
  • Infliximab / administration & dosage
  • Infliximab / adverse effects*
  • Remission Induction
  • Skin / drug effects*
  • Skin / pathology
  • Treatment Outcome

Substances

  • Gastrointestinal Agents
  • Glucocorticoids
  • Azithromycin
  • Clobetasol
  • Infliximab
  • Azathioprine